![Ali Tehrani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ali Tehrani
Fondateur chez
Student Biotechnology Network
Profil
Ali Tehrani was the founder of Zymeworks BC, Inc., founded in 2003, holding the titles of President, Chief Executive Officer & Director from 2003 to 2022.
Dr. Tehrani is also the founder of Student Biotechnology Network.
Current jobs include Director at BIOTECanada since 2021, Director at Consortium Québécois sur la Découverte du Médicament, Director at Creatus Biosciences, Inc. since 2015, Director at Reverb Therapeutics, Inc. since 2023, Partner at Amplitude Ventures since 2023, and Board Member at Qurcan Therapeutics, Inc. since 2022.
Former jobs include President & Chief Executive Officer at Zymeworks, Inc. from 2013 to 2022, Director at LifeSciences British Columbia, and Council Member at Premier's Technology Council from 2016 to 2018.
Education includes a doctorate from the University of British Columbia conferred in 2003, and undergraduate and graduate degrees from the University of Massachusetts conferred in 1994 and 1996 respectively.
Postes actifs de Ali Tehrani
| Sociétés | Poste | Début |
|---|---|---|
Student Biotechnology Network | Fondateur | - |
Consortium Québécois sur la Découverte du Médicament
 Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company | Directeur/Membre du Conseil | - |
Creatus Biosciences, Inc.
 Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a synthetic biology company that develops next generation bio refinery platforms for commercial bio based processes | Directeur/Membre du Conseil | 01/01/2015 |
BIOTECanada
 BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | 03/06/2021 |
Amplitude Ventures
 Amplitude Ventures Investment ManagersFinance Amplitude Ventures is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of healthcare and medicine innovation sectors. It provides financing for early stage capital requirements. | Private Equity Investor | 01/03/2022 |
Reverb Therapeutics
 Reverb Therapeutics BiotechnologyHealth Technology Develops cytokine therapies for oncology and auto-immune diseases | Directeur/Membre du Conseil | 01/07/2023 |
Qurcan Therapeutics, Inc. | Directeur/Membre du Conseil | 01/01/2022 |
Anciens postes connus de Ali Tehrani
| Sociétés | Poste | Fin |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Fondateur | 15/01/2022 |
| ZYMEWORKS INC. | Directeur Général | 15/01/2022 |
| ░░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Ali Tehrani
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Massachusetts
 University of Massachusetts Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Premier's Technology Council
 Premier's Technology Council General GovernmentGovernment Promotes economic development through technology | Government |
LifeSciences British Columbia
 LifeSciences British Columbia BiotechnologyHealth Technology Supports and represents the biotechnology and greater life sciences community of Britsh Columbia | Health Technology |
BIOTECanada
BIOTECanada BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Student Biotechnology Network | |
Consortium Québécois sur la Découverte du Médicament
Consortium Québécois sur la Découverte du Médicament Miscellaneous Commercial ServicesCommercial Services Operates as a drug discovery company | Commercial Services |
Creatus Biosciences, Inc.
Creatus Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a synthetic biology company that develops next generation bio refinery platforms for commercial bio based processes | Commercial Services |
Amplitude Ventures
Amplitude Ventures Investment ManagersFinance Amplitude Ventures is an active manager which invests in companies located in Canada. The firm targets companies operating in the fields of healthcare and medicine innovation sectors. It provides financing for early stage capital requirements. | Finance |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Reverb Therapeutics
Reverb Therapeutics BiotechnologyHealth Technology Develops cytokine therapies for oncology and auto-immune diseases | Health Technology |
Qurcan Therapeutics, Inc. |
